Mackenzie US Mid Cap Opportunities Fund F
MFC8113

This mutual fund is not available for purchase through TD Direct Investing as it carries a trailing commission. The mutual fund provider has posted an alternative that does not have a trailing commission which can be found on the summary page for MFC8112 and the fund's Fund Facts. TD Direct Investing is not responsible for the accuracy of that data.
  • NAV
    15.28
  • TODAY'S CHANGE (%)
    0.14 (0.94%)
  • Investment Style
    Mid Cap Growth
  • 52 Week Range
    12.54
    15.41
  • Distribution Yield
    0.00%
  • MER
    1.05
  • AUM
    767.0M
  • RRSP Eligibility
    Yes
  • Load Type
    No Load
  • Overall Morningstar Rating
    out of 405 funds

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Performance

Graph. See accessible table below

Analyst Report

No reports available

Calendar Year Total Returns

YearFundBest-Fit IndexCategory
As of 2024-10-31
2023
+12.74%
+22.90%
+12.15%
2022
-18.00%
-12.16%
-15.10%
2021
+26.85%
+27.61%
+22.86%
2020
---
+16.32%
+9.87%
2019
---
+24.84%
+17.85%

Holdings Diversification

Asset Class
US Equity		95.8%
Cash		4.3%
CDN Equity		0
Fixed Income		0
Int'l Equity		0
Other		0.0%
Sectors
Technology42.6%
Healthcare29.0%
Industrials13.3%
Financial Serv.s5.1%
Real Estate4.8%
Consumer Cyclical1.0%
Basic Mat.0
Communication Services0
Consumer Defensive0
Energy0
Utilities0
Geographic Region
United States		100.0%
Latin America		0
Africa		0
Asia/Oceania		0
Canada		0
Europe		0
As of 2024-08-31

Top 10 Holdings

Company NamePositionAllocation
Allocation
1 Month Change
Market Value
EXLS
ExlService Holdings Inc
Long
5.8%
0.00%
$101.8M
AKAM
Akamai Technologies Inc
Long
5.1%
0.00%
$88.7M
TECH
Bio-Techne Corp
Long
5.0%
0.00%
$87.0M
CSGP
CoStar Group Inc
Long
4.8%
0.00%
$84.1M
CRUS
Cirrus Logic Inc
Long
4.8%
0.00%
$83.5M
SSNC
SS&C Technologies Holdings Inc
Long
4.7%
0.00%
$82.7M
CRL
Charles River Laboratories International Inc
Long
4.6%
0.00%
$80.3M
MMS
Maximus Inc
Long
4.5%
0.00%
$78.5M
VNT
Vontier Corp Ordinary Shares
Long
4.5%
0.00%
$78.4M
HOLX
Hologic Inc
Long
4.3%
+9.43%
$75.5M
As of 2024-11-12
Fund Profile
Best Fit Index
S&P 500 TR CAD
Category
US Small/Mid Cap Equity
Sponsor
Mackenzie Investments
Inception
May 27, 2020
As of 2024-08-31

The Fund seeks to provide long-term capital growth and a reasonable rate of return by investing primarily in equity securities of mid-capitalization companies in the United States. The Fund will pursue this objective by investing in securities directly and/or by investing in other mutual funds.

Holding Details
Total Net Assets$406.4M
Annual Portfolio Turnover29.53%
Equity Style
Mid Cap Growth
Credit Quality / Duration
---
Tax-Adjusted Rating
Not Rated
FUND IS OPEN TO NEW INVESTORS
Initial Investment(s)$500
Subsequent Investment(s)$100
Initial RRSP Investment(s)$500
Subsequent RRSP Investment(s)$100
Fees & Expenses
Maximum Initial Sales Fees---
Maximum Deferred Sales Fees---
Actual Management Fee0.80%
Actual Mgmt. Expense Ratio (MER)1.05%
Load TypeNo Load

Morningstar Ratings

Time HorizonStar Rating
Tax-Adjusted Rating
Overall
---
3 Year
---
5 YearNot Rated---
10 YearNot Rated---
As of 2024-10-31

Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.

Style Box is calculated only using the long position holdings of the portfolio.

Management & Contact

Contact Information

Mackenzie Investments
180 Queen Street West
Toronto ON Canada M5V 3K1
Tel: 416-922-5322
Fax: 416-922-5660
Portfolio Manager since May 27, 2020
Philip Taller